Cargando…
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy has not been assessed adequately in vulnerable older people who exhibit suboptimal responses after primary vaccination series. This observational study, which was carried out by the VIVALDI study based in Engla...
Autores principales: | Tut, Gokhan, Lancaster, Tara, Krutikov, Maria, Sylla, Panagiota, Bone, David, Spalkova, Eliska, Bentley, Christopher, Amin, Umayr, Jadir, Azar, Hulme, Samuel, Kaur, Nayandeep, Tut, Elif, Bruton, Rachel, Wu, Mary Y., Harvey, Ruth, Carr, Edward J., Beale, Rupert, Stirrup, Oliver, Shrotri, Madhumita, Azmi, Borscha, Fuller, Christopher, Baynton, Verity, Irwin-Singer, Aidan, Hayward, Andrew, Copas, Andrew, Shallcross, Laura, Moss, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154221/ https://www.ncbi.nlm.nih.gov/pubmed/37118525 http://dx.doi.org/10.1038/s43587-022-00328-3 |
Ejemplares similares
-
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
por: Tut, Gokhan, et al.
Publicado: (2022) -
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
por: Tut, Gokhan, et al.
Publicado: (2021) -
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
por: Stirrup, Oliver, et al.
Publicado: (2022) -
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
por: Tut, Gokhan, et al.
Publicado: (2022) -
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
por: Krutikov, Maria, et al.
Publicado: (2022)